133 related articles for article (PubMed ID: 28841582)
1. Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.
Ateba Ndongo F; Texier G; Ida Penda C; Tejiokem MC; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Warszawski J;
Pediatr Infect Dis J; 2018 Jan; 37(1):78-84. PubMed ID: 28841582
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008-2013, Cameroon).
Ndongo FA; Tejiokem MC; Penda CI; Ndiang ST; Ndongo JA; Guemkam G; Sofeu CL; Tagnouokam-Ngoupo PA; Kfutwah A; Msellati P; Faye A; Warszawski J
BMC Pediatr; 2021 Apr; 21(1):189. PubMed ID: 33882903
[TBL] [Abstract][Full Text] [Related]
3. Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
Ateba Ndongo F; Warszawski J; Texier G; Penda I; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Tejiokem MC;
BMC Pediatr; 2015 Sep; 15():132. PubMed ID: 26391474
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.
Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC
BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737
[TBL] [Abstract][Full Text] [Related]
5. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
Shiau S; Strehlau R; Technau KG; Patel F; Arpadi SM; Coovadia A; Abrams EJ; Kuhn L
AIDS; 2017 Jan; 31(3):355-364. PubMed ID: 27828785
[TBL] [Abstract][Full Text] [Related]
6. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
8. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
9. Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.
Ásbjörnsdóttir KH; Hughes JP; Wamalwa D; Langat A; Slyker JA; Okinyi HM; Overbaugh J; Benki-Nugent S; Tapia K; Maleche-Obimbo E; Rowhani-Rahbar A; John-Stewart G
AIDS; 2016 Nov; 30(18):2835-2843. PubMed ID: 27603293
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
[TBL] [Abstract][Full Text] [Related]
11. Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.
Tukei VJ; Murungi M; Asiimwe AR; Migisha D; Maganda A; Bakeera-Kitaka S; Kalyesubula I; Musoke P; Kekitiinwa A
BMC Pediatr; 2013 Mar; 13():42. PubMed ID: 23536976
[TBL] [Abstract][Full Text] [Related]
12. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
[TBL] [Abstract][Full Text] [Related]
14. HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.
van Dijk JH; Sutcliffe CG; Munsanje B; Sinywimaanzi P; Hamangaba F; Thuma PE; Moss WJ
PLoS One; 2011 Apr; 6(4):e19006. PubMed ID: 21552521
[TBL] [Abstract][Full Text] [Related]
15. High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon.
Mbébi Enoné PJ; Penda CI; Ngondi G; Fokam J; Ebong SB; Mekoulou Ndongo J; Essangui Same EG; Ndjengue Nson LS; Mandengue SH; Eboumbou Moukoko CE
PLoS One; 2023; 18(8):e0289426. PubMed ID: 37561800
[TBL] [Abstract][Full Text] [Related]
16. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.
Fokam J; Billong SC; Jogue F; Moyo Tetang Ndiang S; Nga Motaze AC; Paul KN; Njom Nlend AE
PLoS One; 2017; 12(11):e0187566. PubMed ID: 29112991
[TBL] [Abstract][Full Text] [Related]
17. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Virologic Failure on First-line Antiretroviral Therapy Among Children in a Referral Pediatric Center in Cameroon.
Njom Nlend AE; Motaze AN; Ndiang ST; Fokam J
Pediatr Infect Dis J; 2017 Nov; 36(11):1067-1072. PubMed ID: 28661967
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic.
Purkayastha T; Wasi F; Shuter J
AIDS Patient Care STDS; 2005 Dec; 19(12):785-93. PubMed ID: 16375610
[TBL] [Abstract][Full Text] [Related]
20. Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France.
Raho-Moussa M; Guiguet M; Michaud C; Honoré P; Palacios C; Boué F; Azghay M; Kansau I; Chambrin V; Kandel T; Favier M; Miekoutima E; Sayre N; Pignon C; Shoai M; Bouchaud O; Abgrall S
PLoS One; 2019; 14(3):e0213019. PubMed ID: 30845270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
